COMMITMENTS (Details Narrative) - USD ($)						1 Months Ended	12 Months Ended
	Nov. 12, 2024	Oct. 01, 2024	Sep. 23, 2024	Sep. 20, 2024	Apr. 01, 2024	Aug. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Product Liability Contingency [Line Items]
Monthly payment						$ 80,000
Issunace of shares	$ 900,000						$ 4,652,000
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares							10,000
Aggregate fair value of the common stock							$ 500,000
Purchase of common stock	30,000
Stock issued value							1,878,000
Net sales
Debt instrument periodic payment							0
Chief Financial Officer [Member]
Product Liability Contingency [Line Items]
Debt instrument periodic payment							50,000
Sale of equity financing debt							850,000
Accounts payable and accrued expense							50,000	$ 0	$ 0
Phase One Clinical Trial [Member]
Product Liability Contingency [Line Items]
Payment for milestone							150,000
Item One And Two [Member]
Product Liability Contingency [Line Items]
Payment for milestone							250,000
Net sales							5,000,000
Item One And Two [Member] | Non-US [Member]
Product Liability Contingency [Line Items]
Payment for milestone							1,500,000
Item Four [Member]
Product Liability Contingency [Line Items]
Payment for milestone							2,500,000
Net sales							$ 50,000,000
Patent product sales							50.00%
Restricted Stock Units (RSUs) [Member] | Chief Financial Officer [Member]
Product Liability Contingency [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares							32,071
Phase Two [Member] | Item One And Two [Member]
Product Liability Contingency [Line Items]
Payment for milestone							$ 250,000
Phase Two Clinical Trial [Member] | Item Three [Member]
Product Liability Contingency [Line Items]
Payment for milestone							500,000
Phase Two Clinical Trial [Member] | Item Four [Member]
Product Liability Contingency [Line Items]
Payment for milestone							250,000
CEO.CA Technologies Ltd [Member]
Product Liability Contingency [Line Items]
Service fee							250
Belair Capital Advisors Inc [Member]
Product Liability Contingency [Line Items]
Service fee							365
Food and Drug Administration [Member] | Item Four [Member]
Product Liability Contingency [Line Items]
Payment for milestone							1,500,000
Master Service And Technology Agreement [Member]
Product Liability Contingency [Line Items]
Payments for vendor advance						$ 900,000	900,000
Bioassay Services Agreement [Member] | PreCheck Health Services, Inc. [Member]
Product Liability Contingency [Line Items]
Payments for vendor advance				$ 900,000			900,000
Advisory And Consulting Services Agreement [Member] | CEO.CA Technologies Ltd [Member]
Product Liability Contingency [Line Items]
Service fee			$ 250,000				250,000
Strategic Advisory Agreement [Member] | Restricted Stock Units (RSUs) [Member]
Product Liability Contingency [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares			50,000
Strategic Advisory Agreement [Member] | Belair Capital Advisors Inc [Member]
Product Liability Contingency [Line Items]
Service fee			$ 365,000				365,000
Restricted stock units			50,000
Consulting Agreement [Member]
Product Liability Contingency [Line Items]
Issunace of shares		$ 500,000			$ 500,000
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares					367,647
Settlement agreement amount		$ 200,000
Vendor payment advances							200,000
Aggregate fair value of the common stock							500
Consulting Agreement [Member] | Restricted Stock Units (RSUs) [Member]
Product Liability Contingency [Line Items]
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares		367,647
Consulting Agreement [Member] | Current Capital LLC [Member]
Product Liability Contingency [Line Items]
Issunace of shares		$ 200,000
Helena Global Investment Opportunities I LTD [Member]
Product Liability Contingency [Line Items]
Issunace of shares	$ 900,000
Issuance of common shares upon the closing of the initial public offering, net of offering costs, shares	670,641
Stock issued value	$ 1,378,000
License Agreement [Member]
Product Liability Contingency [Line Items]
License fee							5,000
Annual maintenance fee							$ 10,000
Exclusive License Agreement [Member]
Product Liability Contingency [Line Items]
Royalty percentage							3.75%
Exclusive License Agreement [Member] | Item Four [Member]
Product Liability Contingency [Line Items]
License fee							$ 50,000
Annual maintenance fee							$ 10,000
Royalty percentage							4.25%
Minimum requirerment of capital							$ 500,000
Exclusive License Agreement [Member] | Minimum [Member]
Product Liability Contingency [Line Items]
Patent protection costs							$ 9,000
Other non-royalty sublicense fees percentage							5.00%
Exclusive License Agreement [Member] | Minimum [Member] | Item Four [Member]
Product Liability Contingency [Line Items]
Other non-royalty sublicense fees percentage							5.00%
Exclusive License Agreement [Member] | Maximum [Member]
Product Liability Contingency [Line Items]
Patent protection costs							$ 61,000
Other non-royalty sublicense fees percentage							35.00%
Exclusive License Agreement [Member] | Maximum [Member] | Item Four [Member]
Product Liability Contingency [Line Items]
Other non-royalty sublicense fees percentage							35.00%
Enviro Cedars License Agreements [Member] | Phase Three Clinical Trial [Member]
Product Liability Contingency [Line Items]
Net sales							$ 50,000,000
Enviro Cedars License Agreements [Member] | Phase Three [Member] | Item One And Two [Member]
Product Liability Contingency [Line Items]
Net sales							$ 100,000,000